发明名称 |
Nano-scale contrast agents and methods of use |
摘要 |
Compositions and methods are disclosed for evaluating a subject's vasculature integrity, for differentiating between a malignant lesion and a benign lesion, for evaluating the accessibility of a tumor to nano-sized therapeutics, for treating tumors, and for live or real time monitoring of a nano-probe's biodistribution. |
申请公布号 |
US8911708(B2) |
申请公布日期 |
2014.12.16 |
申请号 |
US201213717455 |
申请日期 |
2012.12.17 |
申请人 |
Marval Pharma, Inc. |
发明人 |
Annapragada Ananth;Bellamkonda Ravi V.;Karathanasis Efstathios;Lebovitz Russell M. |
分类号 |
A61K49/00;A61K9/127;A61K49/04 |
主分类号 |
A61K49/00 |
代理机构 |
Benesch, Friedlander, Coplan & Aronoff LLP |
代理人 |
Benesch, Friedlander, Coplan & Aronoff LLP ;Kern Benjamen E.;Anderson Kraig K. |
主权项 |
1. A method for evaluating a subject's vasculature integrity, the method comprising:
introducing a composition into the subject's vasculature, the composition comprising:
liposomes, the liposomes encapsulating one or more iodinated nonradioactive contrast-enhancing agents, and the liposomes comprising:cholesterol,at least one phospholipid, andat least one phospholipid which is derivatized with a polymer chain,wherein the average diameter of the liposomes is less than 150 nanometers; generating images of the subject's vasculature; and analyzing the images to detect a leak in the subject's vasculature, the leak in the subject's vasculature being caused by inflammation or angiogenesis, provided that the inflammation or angiogenesis excludes cancer, stroke, aneurism, healing, and trauma. |
地址 |
New York NY US |